87506 Iadna-dna/rna probe tq 6-11
Also known as: Multiplex infectious disease panel 6-11, pathogen panel
Infectious agent nucleic acid detection for deoxyribonucleic acid or ribonucleic acid targets by probe technique for 6-11 different organisms or strains.
In Plain Language
Multi-pathogen infection test; Comprehensive infection panel
Clinical Context
Multiplex nucleic acid detection of 6-11 different infectious agents for comprehensive diagnostic evaluation of various infections.
RVU Information
CPT 87506 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 87506?
CPT 87506 (Iadna-dna/rna probe tq 6-11) is a Pathology & Lab code. Infectious agent nucleic acid detection for deoxyribonucleic acid or ribonucleic acid targets by probe technique for 6-11 different organisms or strains.
Who uses CPT code 87506?
CPT 87506 is used by Pathology, Infectious Disease, Clinical Microbiology. Multiplex nucleic acid detection of 6-11 different infectious agents for comprehensive diagnostic evaluation of various infections.
When is CPT 87506 used?
Multiplex nucleic acid detection of 6-11 different infectious agents for comprehensive diagnostic evaluation of various infections.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.